Galecto Inc reports results for the quarter ended in December - Earnings Summary

Damora Therapeutics

09/03/2023 20:40

* Galecto Inc  GLTO.OQ  reported a quarterly adjusted loss
of 55
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 57 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galecto Inc's reported EPS for the quarter was a loss
of 55
cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Galecto Inc shares had risen by 81.7% this quarter.
    * The company reported a quarterly loss of $14.07 million.
    * Wall Street's median 12-month price target for Galecto Inc
is
$9.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 08:40 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.57          -0.55          Beat
 Sep. 30 2022      -0.68          -0.54          Beat
 Jun. 30 2022      -0.69          -0.67          Beat